MedTrace Logo

Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions

NCT02631161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2021-06-18

No results posted yet for this study

Summary

A glass hybrid restorative system (EQUIA forte) clinically compared to a composite resin based material (Clearfil SE Bond, Filtek Supreme XT) for the treatment of dental non-carious cervical lesions.

Conditions

  • Dental Cervical Non-carious Lesion

Interventions

OTHER

Equia Forte

Restoration of cavities with a Glasshybrid material (Equia Forte)

OTHER

Filtek Supreme XT/Clearfil SE Bond

Restoration of cavities with a composite resin based material after placing an adhesive

Sponsors & Collaborators

  • GC Europe

    collaborator INDUSTRY

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Sebastian Paris, Prof. Dr. · Abteilung für Zahnerhaltung und Präventivzahnmedizin, Charité Berlin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02631161 on ClinicalTrials.gov